🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Purpose of the Study: This clinical study investigates whether a shorter o...
Status
Recruiting
Location
Amsterdam University Medical Center
Start Date
2026-04-29
Trial ID
NCT07000253
Treatments Being Tested
Pancreatic cancer is difficult to diagnose early. By the time people have b...
Status
Active Not Recruiting
Location
Virginia Mason Medical Center
Start Date
2025-09-24
Trial ID
NCT06396091
Treatments Being Tested
This study will test a new personalized treatment approach for patients wit...
Status
Recruiting
Location
University of California, Los Angeles
Start Date
2026-07-20
Trial ID
NCT07290985
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of sonesit...
Status
Recruiting
Location
Research Site
Start Date
2026-02-03
Trial ID
NCT07431281
The primary objective is to validate, throughout a national real-world stud...
Status
Recruiting
Location
European Institute of Oncology
Start Date
2025-06-20
Trial ID
NCT07427992
This program is to provide zolbetuximab to people with stomach cancer or ga...
Status
Available
Location
Site US10001
Start Date
TBD
Trial ID
NCT06048081
Treatments Being Tested
This study is a prospective, umbrella-design, Phase II clinical trial. Elig...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-01
Trial ID
NCT06881017
The purpose of the trial is to assess the immunological effects and their k...
Status
Completed
Location
Institut für Klinische Forschung, Krankenhaus Nordwest GmbH
Start Date
2012-10-16
Trial ID
NCT01671774
Treatments Being Tested
A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects with ...
Status
Completed
Location
Site CN86001
Start Date
2019-10-18
Trial ID
NCT04086758
Treatments Being Tested
This is an open-label, dose-escalation and dose-expansion phase Ib/IIa clin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07680569
Treatments Being Tested